| (*) | The Finance expenses are mainly attributed to the offerings we made during the nine month period ended September 30, 2019, resulting in issuance expenses of approximately $469,000 that were recognized as finance expenses, and expenses due to changes in the fair value of convertible notes and warrants of approximately $495,000. |
Consolidated Statements of Changes in Equity (Unaudited)
(In thousands of USD)
| Share
capital | Share
premium | Treasury
shares | Presentation
currency translation reserve | Accumulated
loss | Total
equity | |||||||||||||||||||||||||||
| For the nine months ended September 30, 2019: | ||||||||||||||||||||||||||||||||
| Balance as of January 1, 2019 | 3,291 | 63,969 | (1,509 | ) | 1,431 | (51,610 | ) | 15,572 | ||||||||||||||||||||||||
| Issuance of ordinary shares, net | 2,216 | (632 | ) | -- | -- | -- | 1,584 | |||||||||||||||||||||||||
| Exercise of rights to purchase | 52 | 311 | -- | -- | -- | 363 | ||||||||||||||||||||||||||
| Share-based payments | -- | 375 | -- | -- | -- | 375 | ||||||||||||||||||||||||||
| Net loss | -- | -- | -- | -- | (6,972 | ) | (6,972 | ) | ||||||||||||||||||||||||
| Balance as of September 30, 2019 | 5,559 | 64,023 | (1,509 | ) | 1,431 | (58,582 | ) | 10,922 | ||||||||||||||||||||||||
| For the three months ended September 30, 2019: | ||||||||||||||||||||||||||||||||
| Balance as of July 1, 2019 | 5,559 | 63,850 | (1,509 | ) | 1,431 | (54,274 | ) | 15,057 | ||||||||||||||||||||||||
| Share-based payments | -- | 173 | -- | -- | -- | 173 | ||||||||||||||||||||||||||
| Net loss | -- | -- | -- | -- | (4,308 | ) | (4,308 | ) | ||||||||||||||||||||||||
| Balance as of September 30, 2019 | 5,559 | 64,023 | (1,509 | ) | 1,431 | (58,582 | ) | 10,922 | ||||||||||||||||||||||||
